secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0000313143-23-000056
Event type: earnings
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics reports Q2 FY2024 results; specific figures not included in filed document
--------------------------------------------------------------------------------

- Earnings release dated November 2, 2023 for quarter and first half ended September 30, 2023.
- Press release was furnished as Exhibit 99.1 but its text was not provided in the filing.
- No financial metrics, guidance changes, or segment data available for analysis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000056/0000313143-23-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000056/hae-20231102.htm
  HTML page:      https://secwatch.observer/filing/0000313143-23-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer